TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive Only Three Of 28 CCRU, CCSP Proposals Approved, But DRCCA Will Try Again, Board OKs New RFAs May 13, 1983